BRD2 and Infertility: To determine feasibility of the antioxidant intervention in a patient cohort, infertility patients were administered antioxidants for 8–16 (mean 9.9 ± 2.2) weeks (variability due to menstrual cycle dates), immediately preceding follicle-stimulating hormone (FSH) administration (Figure 1b).